Medical Device Deals Update, January 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.
You may also be interested in...
Medtronic is dropping plans to acquire EOFlow, which has faced numerous patent lawsuits from Insulet.
The FDA is set to make a decision on elafibranor for primary biliary cholangitis by June next year, which could give Ipsen a head start over CymaBay's seladelpar.
Earlier dialogues would mean faster access to new medicines.